212 related articles for article (PubMed ID: 10357924)
1. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Trovato MJ; Barber L; Safi HJ; Hagen PO
J Surg Res; 1999 Jun; 84(2):223-32. PubMed ID: 10357924
[TBL] [Abstract][Full Text] [Related]
2. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
3. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
[TBL] [Abstract][Full Text] [Related]
4. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
5. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
[TBL] [Abstract][Full Text] [Related]
6. Alterations in wall tension and shear stress modulate tyrosine kinase signaling and wall remodeling in experimental vein grafts.
Huynh TT; Davies MG; Trovato MJ; Svendsen E; Hagen PO
J Vasc Surg; 1999 Feb; 29(2):334-44. PubMed ID: 9950991
[TBL] [Abstract][Full Text] [Related]
7. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
9. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
10. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
12. Controlling transplant vasculopathy in cryopreserved vein grafts with polyethylene glycol and glutathione during transport.
Davies MG; Huynh TT; Fulton GJ; Svendsen E; Brockbank FG; Hagen PO
Eur J Vasc Endovasc Surg; 1999 Jun; 17(6):493-500. PubMed ID: 10375485
[TBL] [Abstract][Full Text] [Related]
13. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
14. Reduction of vein graft intimal hyperplasia and preservation of endothelium-dependent relaxation by topical vascular endothelial growth factor.
Luo Z; Asahara T; Tsurumi Y; Isner JM; Symes JF
J Vasc Surg; 1998 Jan; 27(1):167-73. PubMed ID: 9474095
[TBL] [Abstract][Full Text] [Related]
15. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
16. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts.
O'Donohoe MK; Schwartz LB; Radic ZS; Mikat EM; McCann RL; Hagen PO
Ann Surg; 1991 Dec; 214(6):727-32. PubMed ID: 1741654
[TBL] [Abstract][Full Text] [Related]
17. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
[TBL] [Abstract][Full Text] [Related]
18. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
19. Locally applied antisense oligonucleotide to proliferating cell nuclear antigen inhibits intimal thickening in experimental vein grafts.
Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
Ann Vasc Surg; 1998 Sep; 12(5):412-7. PubMed ID: 9732417
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
